Milani et al. found that resistance of BC cells to the 26S proteasome inhibitor bortezomib relies on proteasomal stabilization of ATF4, which upregulates LC3B to activate autophagy [26]. The gene discussed is MAP1LC3B; the disease is breast cancer.